Abstract
Outsourcing functions such as logistics has become an industry trend towards cost-effectiveness and high service level performance. Many firms have acknowledged the benefits of relying on external experts in a need to empower their abilities. The pharmaceutical industry in particular is challenged by constant evolution of their development and manufacturing processes. Outsourcing logistics becomes then an attractive option for firms to focus on their core competencies. However, alongside the numerous benefits of outsourcing, various risks arise with the implementation of this option. This paper contributes to the literature by presenting a decision model that takes into consideration risks of outsourcing logistics in the pharmaceutical supply chain. Risk identification and a multi-criteria risk assessment model using ELECTRE TRI are described.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
